Current ratio spoločnosti Genocea Biosciences Inc
Aká je hodnota metriky Current ratio spoločnosti Genocea Biosciences Inc?
Hodnota metriky Current ratio spoločnosti Genocea Biosciences Inc je 1.35
Aká je definícia metriky Current ratio?
Current ratio je ukazovateľ likvidity, ktorý meria či má spoločnosť dostatok zdrojov na splnenie svojich krátkodobých záväzkov.
The current ratio is an indication of a company's liquidity and measures the capability to meet a company's short-term obligations. It compares a firm's current assets to its current liabilities, and is expressed as current assets divided by current liabilities. The ratio is only useful when two companies are compared within industry because inter industry business operations differ substantially. To determine liquidity, the current ratio is not as helpful as the quick ratio, because it includes all those assets that may not be easily liquidated, like prepaid expenses and inventory.
Acceptable current ratios vary from industry to industry. In many cases an investor would consider a high current ratio to be better than a low current ratio, because a high current ratio indicates that the company is more likely to pay the investor back. Large current ratios are not always a good sign for investors. If the company's current ratio is too high it may indicate that the company is not efficiently using its current assets or its short-term financing facilities. If current liabilities exceed current assets the current ratio will be less than 1. A current ratio of less than 1 indicates that the company may have problems meeting its short-term obligations.
Some types of businesses can operate with a current ratio of less than one however. If inventory turns into cash much more rapidly than the accounts payable become due, then the firm's current ratio can comfortably remain less than one. Inventory is valued at the cost of acquiring it and the firm intends to sell the inventory for more than this cost. The sale will therefore generate substantially more cash than the value of inventory on the balance sheet. Low current ratios can also be justified for businesses that can collect cash from customers long before they need to pay their suppliers.
Current ratio spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Genocea Biosciences Inc
Čomu sa venuje spoločnosť Genocea Biosciences Inc?
Genocea's mission is to conquer cancer by developing personalized cancer immunotherapies in multiple tumor types. Our unique ATLAS™ platform comprehensively profiles each patient's T cell responses to potential targets, or antigens, on the tumor. ATLAS enables us to optimize the neoantigens for inclusion in our immunotherapies and exclude inhibitory antigens, Inhibigens™, that can exert an immunosuppressive effect. We are advancing two ATLAS-enabled programs: GEN-009, our neoantigen vaccine and GEN-011, our neoantigen-specific cell therapy using T cells derived from peripheral blood.
Firmy s metrikou current ratio podobnou spoločnosti Genocea Biosciences Inc
- Hodnota metriky Current ratio spoločnosti Haidilao International je 1.35
- Hodnota metriky Current ratio spoločnosti Terrascend je 1.35
- Hodnota metriky Current ratio spoločnosti Park24 Co je 1.35
- Hodnota metriky Current ratio spoločnosti NCC je 1.35
- Hodnota metriky Current ratio spoločnosti Scorpio Bulkers Inc je 1.35
- Hodnota metriky Current ratio spoločnosti Scorpio Bulkers je 1.35
- Hodnota metriky Current ratio spoločnosti Genocea Biosciences Inc je 1.35
- Hodnota metriky Current ratio spoločnosti Abcam PLC je 1.35
- Hodnota metriky Current ratio spoločnosti Torrent Pharmaceuticals je 1.35
- Hodnota metriky Current ratio spoločnosti Singapore Telecommunications je 1.35
- Hodnota metriky Current ratio spoločnosti Cooper-Standard Inc je 1.35
- Hodnota metriky Current ratio spoločnosti PeerStream je 1.35
- Hodnota metriky Current ratio spoločnosti Capital Product Partners L P je 1.35